DOCSLIB.ORG

European Journal of Immunology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
European Journal of Immunology European Journal of Immunology Supporting Information for Eur. J. Immunol. 10.1002/eji.200535496 Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis Antje Kahnert, Peter Seiler, Maik Stein, Silke Bandermann, Karin Hahnke, Hans Mollenkopf and Stefan H. E. Kaufmann © 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji.de ΣΣΣ ↑↓ 163 ↑ 143 > 0 anticorrelated ↓ 20 I III II ↑↓ 105 ↑↓ 39 ↑↓ 19 ↑ 86 ↓ 19 ↑ 38 ↓ 1 ↑ 19 ↓ 0 IFN- γγγ 4h IL-4 4h ↑↓ 144 ↑↓ 58 ↑ 124 ↓ 20 ↑ 57 ↓ 1 ΣΣΣ ↑↓ 1331 ↑ 680 > 41 anticorrelated ↓ 692 IV VI V ↑↓ 943 ↑↓ 159 ↑↓ 229 ↑ 411 ↓ 573 ↑ 72 ↓ 46 ↑ 197 ↓ 73 IFN- γγγ 48h IL-4 48h ↑↓ 1102 ↑↓ 388 ↑ 483 ↓ 619 ↑ 269 ↓ 119 IFN- γγγ 4h IL-4 4h Group Fold Change P-value Intensity1 Intensity2 Fold Change P-value Intensity1 Intensity2 Accession # Primary Sequence Name Sequence Description I ↑↑↑ 4.37371 3.18166E-32 657.5683 2877.62183 1.52007 0.22311 124.05638 189.28168 NM_008042 Fprl1 formyl peptide receptor-like 1 I ↑↑↑ 5.19517 2.30606E-23 3173.28125 16666.12305 1.24572 0.04476 1087.70605 1344.94006 NM_011315 Saa3 serum amyloid A 3 I ↑↑↑ 2.05258 3.2031E-06 1358.04822 2813.76611 1.10341 0.60242 697.22046 783.63538 NM_008518 Ltb lymphotoxin B I ↑↑↑ 2.62754 1.24797E-11 3477.42529 9092.96484 1.10201 0.29205 910.6438 1004.36945 NM_008357 Il15 interleukin 15 I ↑↑↑ 2.19028 5.38095E-09 1189.62219 2618.71338 1.83042 0.00007 367.65424 674.255 NM_007548 Prdm1 PR domain containing 1, with ZNF domain I ↑↑↑ 3.16446 4.00706E-07 520.12781 1650.31921 2.23118 0.10955 76.51717 166.07359 NM_009421 Traf1 Tnf receptor-associated factor 1 I ↑↑↑ 2.11787 0.00005 4171.9834 8799.2832 1.47311 0.02326 3451.87598 5111.30762 NM_008152 Gpr65 G-protein coupled receptor 25 I ↑↑↑ 2.91776 4.26711E-10 11832.90039 34579.65234 1.99595 1 9310.50977 18565.26172 NM_009058 Ralgds ral guanine nucleotide dissociation stimulator I ↑↑↑ 4.09402 2.53194E-08 161.28786 660.95789 2.11944 0.12092 81.33522 161.59579 NM_010510 Ifnb1 interferon beta, fibroblast I ↑↑↑ 2.05494 1.21879E-08 632.34619 1300.89612 1.32752 0.03384 599.34027 797.30957 NM_013839 Nr1h3 nuclear receptor subfamily 1, group H, member 3 I ↑↑↑ 2.71144 2.34192E-20 1090.38696 2955.12793 1.80198 1.23369E-06 479.62128 867.71027 NM_021327 Tnip1 Nef-associated factor 1 I ↑↑↑ 6.6489 3.14482E-35 9534.8623 63295.4375 1.71771 0.00016 3515.78125 6029.41797 NM_011611 Tnfrsf5 tumor necrosis factor receptor superfamily, member 5 I ↑↑↑ 2.00794 4.42169E-10 3434.86133 6906.89746 1.74663 0.0003 7131.7998 12386.69336 AW496438 AW496438 ESTs, Moderately similar to KIAA0769 protein [H.sapiens] I ↑↑↑ 8.21634 5.53599E-11 126.95619 1063.02893 2.06777 0.17241 80.90722 142.85664 M86671 Il12b interleukin 12b I ↑↑↑ 3.08212 2.66256E-17 2299.72461 7106.50586 1.44944 0.00882 423.29254 612.73071 AI043056 X83327 EST X83327 I ↑↑↑ 2.04268 2.18937E-07 2181.60986 4447.53076 1.16099 0.06864 555.50269 644.98157 AI450152 AI450152 ESTs I ↑↑↑ 2.21743 2.88452E-18 3962.47314 8788.41602 1.46842 0.00016 2246.23047 3309.95142 AI326880 AI326880 ESTs, Highly similar to ZINC FINGER PROTEIN 7 [Homo sapiens] I ↑↑↑ 2.67948 3.68232E-06 164.38525 439.54199 2.1368 0.0086 63.8369 137.24866 NM_009397 Tnfaip3 tumor necrosis factor, alpha-induced protein 3 I ↑↑↑ 2.00609 1.57233E-08 191.7652 383.59735 1.85161 4.41058E-08 341.56604 631.33923 AF068748 Sphk1 sphingosine kinase 1 I ↑↑↑ 9.23315 3.43792E-34 4778.18652 44401.78906 -1.00508 0.98534 389.77069 398.48138 NM_019494 Cxcl11 small inducible cytokine subfamily B (Cys-X-Cys), member 11 I ↑↑↑ 2.11276 3.56719E-09 24075.94531 50742.71094 2.13895 0.00096 12943.9873 27685.65234 NM_013562 Ifrd1 interferon-related developmental regulator 1 I ↑↑↑ 2.83923 1.5042E-08 433.24518 1246.83594 1.70746 0.0015 220.08766 383.80035 BB532105 BB532105 ESTs I ↑↑↑ 2.64545 0.00037 18511.69336 49544.16797 1.66114 0.04491 11596.39258 19641.90039 NM_008102 Gch1 GTP cyclohydrolase 1 I ↑↑↑ 5.02574 0 177.73532 893.58356 1.8875 0.06782 77.14024 146.35068 NM_008361 Il1b interleukin 1 beta I ↑↑↑ 3.69403 4.6101E-39 983.32678 3628.97119 1.45525 0.09065 78.51878 115.46391 BE197977 BE197977 ESTs, Moderately similar to GPRI_HUMAN PROBABLE G PROTEIN-COUPLED RECEPTOR GPR18 [H.sapiens] I ↑↑↑ 2.88868 3.47018E-07 683.92633 2005.10156 1.77378 0.01264 1403.203 2505.11768 M12571 Hspa1a heat shock protein, 70 kDa 3 I ↑↑↑ 2.86649 3.6846E-34 293.7431 841.94922 1.58011 0.08123 70.09181 112.63826 AI481176 AI481176 ESTs I ↑↑↑ 2.00309 3.90637E-06 3355.87695 6695.66553 1.48713 0.0008 1102.73145 1636.25061 BF018243 BF018243 ESTs, Weakly similar to neuronal tyrosine threonine phosphatase 1 [M.musculus] I ↑↑↑ 3.40016 2.79279E-42 1994.36853 6780.56152 1.81468 8.6822E-10 544.91968 990.34894 K02782 C3 complement component 3 I ↑↑↑ 2.89001 7.9468E-08 188.33945 544.81531 1.66649 0.00778 61.42165 102.44063 NM_013521 Fpr1 formyl peptide receptor 1 I ↑↑↑ 2.29034 0.00003 5634.97363 12982.96094 1.20636 0.29849 3055.42603 3737.53076 BE630688 BE630688 Mus musculus SAMSN1 mRNA, complete cds I ↑↑↑ 2.07181 0.00022 1336.53442 2771.52563 -1.062 0.76551 1377.33862 1301.38 NM_009366 Tgfb1i4 transforming growth factor beta 1 induced transcript 4 I ↑↑↑ 2.66471 0.00097 19612.94531 53320.54688 1.51894 0.22443 11305.49121 17279.91406 NM_011018 Sqstm1 oxidative stress induced I ↑↑↑ 2.35207 6.2387E-09 6482.23486 15209.37109 1.33676 0.06506 17149.98438 22561.96484 AF077742 Tcfec transcription factor EC I ↑↑↑ 2.27641 0.00026 1901.43042 4374.19873 1.44067 0.0686 1278.10059 1895.49438 BB206914 BB206914 EST, Moderately similar to TDA8_MOUSE PROBABLE G PROTEIN-COUPLED RECEPTOR TDAG8 [M.musculus] I ↑↑↑ 2.29113 1.62838E-22 762.08685 1746.00146 1.4563 0.00021 405.23706 593.46002 AF199491 Ccrn4l Mus musculus NOCTURNIN (Nocturnin) mRNA, complete cds I ↑↑↑ 4.05415 3.18035E-22 5545.58887 22339.75977 1.7557 5.13114E-08 2804.34302 4899.48242 NM_009841 Cd14 CD14 antigen I ↑↑↑ 3.58344 4.8033E-29 1387.31335 4966.97461 1.38684 0.02403 108.1729 149.59058 NM_008039 Fpr-rs2 formyl peptide receptor, related sequence 2 I ↑↑↑ 2.23795 0.00008 3286.36963 7412.73828 1.44845 0.04014 2613.5498 3863.97217 BB201573 BB201573 EST, Moderately similar to TDA8_MOUSE PROBABLE G PROTEIN-COUPLED RECEPTOR TDAG8 [M.musculus] I ↑↑↑ 2.87144 4.6969E-14 596.01801 1711.35645 1.03944 0.82593 299.34717 315.59778 NM_008903 Ppap2a phosphatidic acid phosphatase 2a I ↑↑↑ 3.64964 0 2853.29468 10410.93164 1.52968 4.5241E-06 1810.38037 2764.46729 BF020125 BF020125 ESTs, Moderately similar to unnamed protein product [H.sapiens] I ↑↑↑ 4.17109 1.47823E-41 1067.51404 4457.05078 1.67225 6.66339E-09 581.08875 970.03125 AI256591 AI256591 ESTs I ↑↑↑ 2.21896 7.01942E-14 1157.37402 2569.28491 1.65634 5.40206E-06 1713.38989 2851.83643 AI385691 AI385691 ESTs, Highly similar to P2UR_MOUSE P2U PURINOCEPTOR 1 [M.musculus] I ↑↑↑ 3.96552 0 1402.82056 5562.91992 1.12731 0.48849 456.55466 523.0871 NM_011171 Procr protein C receptor, endothelial I ↑↑↑ 2.71738 1.0795E-08 187.99223 503.92175 1.90544 0.00006 126.05093 240.19389 NM_009705 Arg2 arginase type II I ↑↑↑ 3.78329 5.84249E-07 38.94953 149.17516 1.03208 0.89196 33.66799 46.68737 NM_008335 Ifna6 interferon alpha family, gene 8 I ↑↑↑ 3.0662 1.57409E-34 1143.69238 3507.18066 1.18259 0.49032 200.3089 243.61404 NM_007981 Acsl1 fatty acid Coenzyme A ligase, long chain 2 I ↑↑↑ 2.21769 0.00007 744.73987 1634.55273 1.5401 0.05251 387.71252 592.02271 U70139 Ccrn4l carbon catabolite repression 4 homolog (S. cerevisiae) I ↑↑↑ 2.29641 4.18685E-13 108.651 249.66084 1.21863 0.39744 54.1762 66.04936 NM_008334 Ifna7 interferon alpha family, gene 7 I ↑↑↑ 2.06633 9.72754E-10 35713.98438 73443.47656 -1.09533 0.3712 5063.5083 4606.9209 BE989134 BE989134 ESTs I ↑↑↑ 2.11446 4.86847E-10 1026.84802 2162.50024 1.1586 0.49888 161.42722 186.97969 AI662827 AI662827 EST I ↑↑↑ 8.7791 0 134.91577 1185.65088 -1.46506 0.51574 56.97549 48.10512 NM_010927 Nos2 nitric oxide synthase 2, inducible, macrophage I ↑↑↑ 2.11885 1.86993E-18 515.1369 1090.88196 -1.78033 2.89755E-08 1350.4718 761.11597 NM_008059 G0s2 G0/G1 switch gene 2 I ↑↑↑ 2.40796 1.38279E-20 1853.20093 4464.31006 1.42495 0.0017 550.86298 783.47217 AW494132 AW494132 ESTs I ↑↑↑ 2.77651 7.98765E-19 2321.85669 6405.04785 1.26154 0.31297 7285.89502 9191.80273 NM_008808 Pdgfa platelet derived growth factor, alpha I ↑↑↑ 2.2269 0.0015 2952.04736 6459.98193 1.28441 0.24627 1200.33838 1521.604 NM_016767 Batf basic leucine zipper transcription factor, ATF-like I ↑↑↑ 2.0958 9.06144E-18 4420.35547 9268.5957 1.38628 0.00017 2662.11426 3686.81592 AI644220 AI644220 ESTs, Moderately similar to AF151825_1 CGI-67 protein [H.sapiens] I ↑↑↑ 2.86253 1.7611E-31 380.98676 1091.64966 1.38586 0.02997 288.3887 403.92831 AI450672 AI450672 ESTs I ↑↑↑ 2.4308 5.379E-14 325.24634 792.36566 1.07865 0.5865 130.77739 141.36136 BE634799 BE634799 ESTs I ↑↑↑ 2.59239 2.69375E-23 232.59319 603.50049 1.05781 0.76035 101.11175 107.39954 NM_019564 Prss11 insulin-like growth factor binding protein 5 protease I ↑↑↑ 3.52777 1.84335E-15 121.72289 435.10095 1.3962 0.20785 104.27471 140.54333 NM_010554 Il1a interleukin 1 alpha I ↑↑↑ 2.22767 5.81309E-13 204.85254 454.69531 1.18062 0.114 404.96429 476.79102 NM_007413 Adora2b adenosine A2b receptor I ↑↑↑ 2.24517 3.98988E-12 2791.5459 6245.95215 1.80281 8.02644E-06 791.17444 1417.79346 NM_019777 Ikbke inducible IKappaB kinase I ↑↑↑ 2.42382 7.25447E-08 715.04272 1743.58276 1.15808 0.4743 302.71609 359.75955 NM_010612 Kdr kinase insert domain protein receptor I ↑↑↑ 2.16073 7.65005E-14 45766.27344 99207.39062 1.50038 0.00006 39259.45312 59076.94141 NM_013885 Clic4 chloride intracellular channel 4 (mitochondrial) I ↑↑↑ 2.50669 8.07447E-09
Load more

Recommended publications
  • Species-Specific Difference in Expression and Splice-Site Choice In
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Mamm Genome (2010) 21:458–466 DOI 10.1007/s00335-010-9281-7 Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome Susan P. Bothwell • Leslie W. Farber • Adam Hoagland • Robert L. Nussbaum Received: 11 June 2010 / Accepted: 31 August 2010 / Published online: 26 September 2010 Ó The Author(s) 2010. This article is published with open access at Springerlink.com Abstract The oculocerebrorenal syndrome of Lowe Inpp5b/INPP5B are the most highly conserved paralogs to (OCRL; MIM #309000) is an X-linked human disorder Ocrl/OCRL in the respective genomes of both species and characterized by congenital cataracts, mental retardation, Inpp5b demonstrates functional overlap with Ocrl in mice and renal proximal tubular dysfunction caused by loss-of- in vivo. We used in silico sequence analysis, reverse-tran- function mutations in the OCRL gene that encodes Ocrl, a scription PCR, quantitative PCR, and transient transfection type II phosphatidylinositol bisphosphate (PtdIns4,5P2) assays of promoter function to define splice-site usage and 5-phosphatase. In contrast, mice with complete loss-of- the function of an internal promoter in mouse Inpp5b function of the highly homologous ortholog Ocrl have no versus human INPP5B. We found mouse Inpp5b and detectable renal, ophthalmological, or central nervous human INPP5B differ in their transcription, splicing, and system abnormalities. We inferred that the disparate phe- primary amino acid sequence. These observations form the notype between Ocrl-deficient humans and mice was likely foundation for analyzing the functional basis for the dif- due to differences in how the two species compensate for ference in how Inpp5b and INPP5B compensate for loss of loss of the Ocrl enzyme.
    [Show full text]
  • Full-Length Cdna, Expression Pattern and Association Analysis of the Porcine FHL3 Gene
    1473 Asian-Aust. J. Anim. Sci. Vol. 20, No. 10 : 1473 - 1477 October 2007 www.ajas.info Full-length cDNA, Expression Pattern and Association Analysis of the Porcine FHL3 Gene Bo Zuo*, YuanZhu Xiong, Hua Yang and Jun Wang Key Laboratory of Swine Genetics and Breeding, Ministry of Agriculture & Key Lab of Agricultural Animal Genetics, Breeding and Reproduction, Ministry of Education, College of Animal Science and Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, P. R. China ABSTRACT : Four-and-a-half LIM-only protein 3 (FHL3) is a member of the LIM protein superfamily and can participate in mediating protein-protein interaction by binding one another through their LIM domains. In this study, the 5'- and 3'- cDNA ends were characterized by RACE (Rapid Amplification of the cDNA Ends) methodology in combination with in silica cloning based on the partial cDNA sequence obtained. Bioinformatics analysis showed FHL3 protein contained four LIM domains and four LIM zinc-binding domains. In silica mapping assigned this gene to the gene cluster MTF1-INPP5B-SF3A3-FHL3-CGI-94 on pig chromosome 6 where several QTL affecting intramuscular fat and eye muscle area had previously been identified. Transcription of the FHL3 gene was detected in spleen, liver, kidney, small intestine, skeletal muscle, fat and stomach, with the greatest expression in skeletal muscle. The A/G polymorphism in exon II was significantly associated with birth weight, average daily gain before weaning, drip loss rate, water holding capacity and intramuscular fat in a Landrace-derived pig population. Together, the present study provided the useful information for further studies to determine the roles of FHL3 gene in the regulation of skeletal muscle cell growth and differentiation in pigs.
    [Show full text]
  • Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model
    BASIC RESEARCH www.jasn.org Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model Megan L. Gliozzi,1 Eugenel B. Espiritu,2 Katherine E. Shipman,1 Youssef Rbaibi,1 Kimberly R. Long,1 Nairita Roy,3 Andrew W. Duncan,3 Matthew J. Lazzara,4 Neil A. Hukriede,2,5 Catherine J. Baty,1 and Ora A. Weisz1 1Renal-Electrolyte Division, Department of Medicine, 2Department of Developmental Biology, and 3Department of Pathology, McGowan Institute for Regenerative Medicine, and Pittsburgh Liver Research Center, Pittsburgh, Pennsylvania; 4Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia; and 5Center for Critical Care Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania ABSTRACT Background Lowe syndrome (LS) is an X-linked recessive disorder caused by mutations in OCRL,which encodes the enzyme OCRL. Symptoms of LS include proximal tubule (PT) dysfunction typically character- ized by low molecular weight proteinuria, renal tubular acidosis (RTA), aminoaciduria, and hypercalciuria. How mutant OCRL causes these symptoms isn’tclear. Methods We examined the effect of deleting OCRL on endocytic traffic and cell division in newly created human PT CRISPR/Cas9 OCRL knockout cells, multiple PT cell lines treated with OCRL-targeting siRNA, and in orcl-mutant zebrafish. Results OCRL-depleted human cells proliferated more slowly and about 10% of them were multinucleated compared with fewer than 2% of matched control cells. Heterologous expression of wild-type, but not phosphatase-deficient, OCRL prevented the accumulation of multinucleated cells after acute knockdown of OCRL but could not rescue the phenotype in stably edited knockout cell lines. Mathematic modeling confirmed that reduced PT length can account for the urinary excretion profile in LS.
    [Show full text]
  • Qt4ff4w947.Pdf
    eScholarship Title Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome Permalink https://escholarship.org/uc/item/4ff4w947 Journal Mammalian Genome, 21(9) ISSN 1432-1777 Authors Bothwell, Susan P. Farber, Leslie W. Hoagland, Adam et al. Publication Date 2010-10-01 DOI 10.1007/s00335-010-9281-7 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Mamm Genome (2010) 21:458–466 DOI 10.1007/s00335-010-9281-7 Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome Susan P. Bothwell • Leslie W. Farber • Adam Hoagland • Robert L. Nussbaum Received: 11 June 2010 / Accepted: 31 August 2010 / Published online: 26 September 2010 Ó The Author(s) 2010. This article is published with open access at Springerlink.com Abstract The oculocerebrorenal syndrome of Lowe Inpp5b/INPP5B are the most highly conserved paralogs to (OCRL; MIM #309000) is an X-linked human disorder Ocrl/OCRL in the respective genomes of both species and characterized by congenital cataracts, mental retardation, Inpp5b demonstrates functional overlap with Ocrl in mice and renal proximal tubular dysfunction caused by loss-of- in vivo. We used in silico sequence analysis, reverse-tran- function mutations in the OCRL gene that encodes Ocrl, a scription PCR, quantitative PCR, and transient transfection type II phosphatidylinositol bisphosphate (PtdIns4,5P2) assays of promoter function to define splice-site usage and 5-phosphatase. In contrast, mice with complete loss-of- the function of an internal promoter in mouse Inpp5b function of the highly homologous ortholog Ocrl have no versus human INPP5B.
    [Show full text]
  • Robles JTO Supplemental Digital Content 1
    Supplementary Materials An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma based on mRNA, microRNA and DNA Methylation Biomarkers Ana I. Robles1, Eri Arai2, Ewy A. Mathé1, Hirokazu Okayama1, Aaron Schetter1, Derek Brown1, David Petersen3, Elise D. Bowman1, Rintaro Noro1, Judith A. Welsh1, Daniel C. Edelman3, Holly S. Stevenson3, Yonghong Wang3, Naoto Tsuchiya4, Takashi Kohno4, Vidar Skaug5, Steen Mollerup5, Aage Haugen5, Paul S. Meltzer3, Jun Yokota6, Yae Kanai2 and Curtis C. Harris1 Affiliations: 1Laboratory of Human Carcinogenesis, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 2Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 3Genetics Branch, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 4Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 5Department of Chemical and Biological Working Environment, National Institute of Occupational Health, NO-0033 Oslo, Norway. 6Genomics and Epigenomics of Cancer Prediction Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), 08916 Badalona (Barcelona), Spain. List of Supplementary Materials Supplementary Materials and Methods Fig. S1. Hierarchical clustering of based on CpG sites differentially-methylated in Stage I ADC compared to non-tumor adjacent tissues. Fig. S2. Confirmatory pyrosequencing analysis of DNA methylation at the HOXA9 locus in Stage I ADC from a subset of the NCI microarray cohort. 1 Fig. S3. Methylation Beta-values for HOXA9 probe cg26521404 in Stage I ADC samples from Japan. Fig. S4. Kaplan-Meier analysis of HOXA9 promoter methylation in a published cohort of Stage I lung ADC (J Clin Oncol 2013;31(32):4140-7). Fig. S5. Kaplan-Meier analysis of a combined prognostic biomarker in Stage I lung ADC.
    [Show full text]
  • Genomic Sequencing of Lowe Syndrome Trios Reveal a Mechanism For
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.22.449382; this version posted June 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genomic sequencing of Lowe syndrome trios reveal a mechanism for 2 the heterogeneity of neurodevelopmental phenotypes 3 4 5 6 7 8 9 10 11 Husayn Ahmed Pallikonda*#& , Pramod Singh*&, Rajan Thakur*, Aastha Kumari*, Harini Krishnan*, 12 Ron George Philip*, Anil Vasudevan@ and Padinjat Raghu%*$ 13 14 *National Centre for Biological Sciences, TIFR-GKVK Campus, Bellary Road, Bengaluru-560065, 15 India. 16 %Brain Development and Disease Mechanisms, Institute for Stem Cell Science and Regenerative 17 Medicine, Bengaluru-560065, India. 18 @Department of Pediatric Nephrology, St. John's Medical College Hospital, Bengaluru-560034, India 19 #Present Address: Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK. 20 21 &Equal contribution 22 $Corresponding Author: [email protected] 23 Tel: +91-80-23666102 24 25 26 27 28 29 30 31 32 33 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.06.22.449382; this version posted June 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 34 Abstract 35 Lowe syndrome is an X-linked recessive monogenic disorder resulting from mutations in the OCRL 36 gene that encodes a phosphatidylinositol 4,5 bisphosphate 5-phosphatase.
    [Show full text]
  • Identification of Novel Fusion Transcripts in High Grade Serous
    International Journal of Molecular Sciences Article Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer Andreea Newtson 1,* , Henry Reyes 2, Eric J. Devor 3,4 , Michael J. Goodheart 1,3 and Jesus Gonzalez Bosquet 1,3 1 Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA; [email protected] (M.J.G.); [email protected] (J.G.B.) 2 Department of Obstetrics and Gynecology, University of Buffalo, Buffalo, NY 14260, USA; [email protected] 3 Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA; [email protected] 4 Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA * Correspondence: [email protected]; Tel.: +1-319-356-2015 Abstract: Fusion genes are structural chromosomal rearrangements resulting in the exchange of DNA sequences between genes. This results in the formation of a new combined gene. They have been implicated in carcinogenesis in a number of different cancers, though they have been understudied in high grade serous ovarian cancer. This study used high throughput tools to compare the transcrip- tome of high grade serous ovarian cancer and normal fallopian tubes in the interest of identifying unique fusion transcripts within each group. Indeed, we found that there were significantly more fusion transcripts in the cancer samples relative to the normal fallopian tubes. Following this, the Citation: Newtson, A.; Reyes, H.; role of fusion transcripts in chemo-response and overall survival was investigated. This led to the Devor, E.J.; Goodheart, M.J.; Bosquet, identification of fusion transcripts significantly associated with overall survival.
    [Show full text]
  • Integrated Systems Tool for Eye Gene Discovery Salil A. Lachke,1,2,9
    Lachke et al., 1 iSyTE: integrated Systems Tool for Eye gene discovery Salil A. Lachke,1,2,9 Joshua W.K. Ho,1,3,9 Gregory V. Kryukov,1,4,9 Daniel J. O’Connell,1 Anton Aboukhalil,1,5 Martha L. Bulyk,1,6,7 Peter J. Park,1,3,8 Richard L. Maas1* Affiliations: 1 Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 USA 2 Department of Biological Sciences and Center for Bioinformatics and Computational Biology, University of Delaware, Newark, DE 19716 USA 3 Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115 USA 4 The Broad Institute, Cambridge, MA 02139 USA 5 Department of Aeronautics and Astronautics, Massachusetts Institute of Technology, Cambridge, MA 02139 USA 6 Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 USA 7 Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology (HST), Harvard Medical School, Boston, MA 02115, USA 8 Informatics Programs, Children’s Hospital of Boston, Boston, MA 02115, USA 9 Authors contributed equally * Correspondence: [email protected] (R.L.M.) Word Count of Text: 3722 Grant Information: This work was supported by NIH grants R01EY10123-15 to RLM and R01EY021505-01 to SAL. JWKH was supported by the NIH Common Fund via NIBIB RL9EB008539. Lachke et al., 2 ABSTRACT PURPOSE: To facilitate the identification of genes associated with cataract and other ocular defects, we developed and validated a computational tool termed iSyTE (integrated Systems Tool for Eye gene discovery; http://bioinformatics.udel.edu/Research/iSyTE).
    [Show full text]
  • Integrated Cellular and Plasma Proteomics of Contrasting B-Cell Cancers Reveals Common, Unique and Systemic Signatures*□S
    crossmark Research © 2017 by The American Society for Biochemistry and Molecular Biology, Inc. This paper is available on line at http://www.mcponline.org Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures*□S Harvey E. Johnston‡§, Matthew J. Carter‡, Kerry L. Cox‡, Melanie Dunscombe‡, Antigoni Manousopoulou§¶, Paul A. Townsendʈ, Spiros D. Garbis§¶, and Mark S. Cragg‡** Approximately 800,000 leukemia and lymphoma cases are both subunits of the interleukin-5 (IL5) receptor. IL5 treat- diagnosed worldwide each year. Burkitt’s lymphoma (BL) ment promoted E␮-TCL1 tumor proliferation, suggesting and chronic lymphocytic leukemia (CLL) are examples of an amplification of IL5-induced AKT signaling by TCL1. contrasting B-cell cancers; BL is a highly aggressive Tumor plasma contained a substantial tumor lysis signa- Downloaded from lymphoid tumor, frequently affecting children, whereas ture, most prominent in E␮-myc plasma, whereas E␮- CLL typically presents as an indolent, slow-progressing TCL1 plasma contained signatures of immune-response, leukemia affecting the elderly. The B-cell-specific overex- inflammation and microenvironment interactions, with pression of the myc and TCL1 oncogenes in mice induce putative biomarkers in early-stage cancer. These findings spontaneous malignancies modeling BL and CLL, respec- provide a detailed characterization of contrasting B-cell http://www.mcponline.org/ tively. Quantitative mass spectrometry proteomics and tumor models, identifying common and specific tumor isobaric labeling were employed to examine the biology mechanisms. Integrated plasma proteomics allowed the underpinning contrasting E␮-myc and E␮-TCL1 B-cell tu- dissection of a systemic response and a tumor lysis sig- mors.
    [Show full text]
  • DATA ANALYSIS and CREATION of EPIGENETICS DATABASE Akshay
    DATA ANALYSIS AND CREATION OF EPIGENETICS DATABASE Akshay A Desai Submitted to the faculty of the Bioinformatics Graduate Program in partial fulfillment of the requirements for the degree Master of Science in Bioinformatics in the School of Informatics Indiana University December 2013 Accepted by the Graduate faculty, Indiana University, in partial fulfillment of the requirements for the degree of Master of Science in Bioinformatics Master’s Thesis Committee Mathew Palakal, Ph.D. Huanmei Wu, Ph.D. Xiaowen Liu, Ph.D. ii Copyright page © 2013 Akshay Ashok Desai ALL RIGHTS RESERVED iii To my parents, Mr. Ashok B. Desai and Mrs. Vidya A. Desai and my family. They raised me, supported me, taught me and loved me. This thesis is dedicated to them. iv Acknowledgement This thesis was made possible due to the guidance and encouragement from many people. So it gives me a great pleasure to thank these people and acknowledge their contribution. I owe a sincere appreciation to my thesis advisor Dr Mathew Palakal for his motivation and immense knowledge. Without his thoughtful guidance, energy and constructive criticism this thesis would have never been possible. I would like to thank Dr Meeta Pradhan for her role in my thesis completion. Besides my lab members, I would also like to thank the other members of my committee Dr Huanmei Wu and Dr Xiaowen Liu for supporting my work, reading my thesis and providing helpful suggestions. I wish to express sincere appreciation to School of Informatics at Indiana University Purdue University Indianapolis for providing me an opportunity to pursue a bright carrier in bioinformatics.
    [Show full text]
  • Digenic Mutations of Human OCRL Paralogs in Dent's Disease Type 2
    OPEN Citation: Human Genome Variation (2016) 3, 16042; doi:10.1038/hgv.2016.42 Official journal of the Japan Society of Human Genetics www.nature.com/hgv ARTICLE Digenic mutations of human OCRL paralogs in Dent’s disease type 2 associated with Chiari I malformation Daniel Duran1,11, Sheng Chih Jin2,11, Tyrone DeSpenza Jr1,11, Carol Nelson-Williams2,3, Andrea G Cogal4, Elizabeth W Abrash4, Peter C Harris4,5, John C Lieske4,6,7, Serena JE Shimshak1, Shrikant Mane8, Kaya Bilguvar8, Michael L DiLuna1, Murat Günel1,2, Richard P Lifton3 and Kristopher T Kahle1,9,10 OCRL1 and its paralog INPP5B encode phosphatidylinositol 5-phosphatases that localize to the primary cilium and have roles in ciliogenesis. Mutations in OCRL1 cause the X-linked Dent disease type 2 (DD2; OMIM# 300555), characterized by low-molecular weight proteinuria, hypercalciuria, and the variable presence of cataracts, glaucoma and intellectual disability without structural brain anomalies. Disease-causing mutations in INPP5B have not been described in humans. Here, we report the case of an 11-year- old boy with short stature and an above-average IQ; severe proteinuria, hypercalciuria and osteopenia resulting in a vertebral compression fracture; and Chiari I malformation with cervico-thoracic syringohydromyelia requiring suboccipital decompression. Sequencing revealed a novel, de novo DD2-causing 462 bp deletion disrupting exon 3 of OCRL1 and a maternally inherited, extremely rare (ExAC allele frequency 8.4 × 10− 6) damaging missense mutation in INPP5B (p.A51V). This mutation substitutes an evolutionarily conserved amino acid in the protein’s critical PH domain. In silico analyses of mutation impact predicted by SIFT, PolyPhen2, MetaSVM and CADD algorithms were all highly deleterious.
    [Show full text]
  • Systems Biology Approach to Stage-Wise Characterization of Epigenetic Genes in Lung Adenocarcinoma Meeta P Pradhan†, Akshay Desai† and Mathew J Palakal*
    Pradhan et al. BMC Systems Biology 2013, 7:141 http://www.biomedcentral.com/1752-0509/7/141 RESEARCH ARTICLE Open Access Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma Meeta P Pradhan†, Akshay Desai† and Mathew J Palakal* Abstract Background: Epigenetics refers to the reversible functional modifications of the genome that do not correlate to changes in the DNA sequence. The aim of this study is to understand DNA methylation patterns across different stages of lung adenocarcinoma (LUAD). Results: Our study identified 72, 93 and 170 significant DNA methylated genes in Stages I, II and III respectively. A set of common 34 significant DNA methylated genes located in the promoter section of the true CpG islands were found across stages, and these were: HOX genes, FOXG1, GRIK3, HAND2, PRKCB, etc. Of the total significant DNA methylated genes, 65 correlated with transcription function. The epigenetic analysis identified the following novel genes across all stages: PTGDR, TLX3, and POU4F2. The stage-wise analysis observed the appearance of NEUROG1 gene in Stage I and its re-appearance in Stage III. The analysis showed similar epigenetic pattern across Stage I and Stage III. Pathway analysis revealed important signaling and metabolic pathways of LUAD to correlate with epigenetics. Epigenetic subnetwork analysis identified a set of seven conserved genes across all stages: UBC, KRAS, PIK3CA, PIK3R3, RAF1, BRAF, and RAP1A. A detailed literature analysis elucidated epigenetic genes like FOXG1, HLA-G, and NKX6-2 to be known as prognostic targets. Conclusion: Integrating epigenetic information for genes with expression data can be useful for comprehending in-depth disease mechanism and for the ultimate goal of better target identification.
    [Show full text]